Literature DB >> 17634219

TR1.3 viral pathogenesis and syncytium formation are linked to Env-Gag cooperation.

Samuel L Murphy1, Glen N Gaulton.   

Abstract

Infection with murine leukemia virus (MLV) TR1.3 or the related molecular construct W102G causes severe neuropathology in vivo. Infection is causally linked to the development of extensive syncytia in brain capillary endothelial cells (BCEC). These viruses also induce cell fusion of murine cell lines, such as SC-1 and NIH 3T3, which are otherwise resistant to MLV-induced syncytium formation. Although the virulence of these viruses maps within the env gene, the mechanism of fusion enhancement is not fully determined. To this end, we examined the capacity of the syncytium-inducing (SI) TR1.3 and W102G MLVs to overcome the fusion inhibitory activity inherent in the full-length Env cytoplasmic tail. These studies showed that the TR1.3 and W102G Envs did not induce premature cleavage of p2E, nor did they override p2E fusion inhibition. Indeed, in the presence of mutations that disrupt p2E function, the TR1.3 and W102G Envs significantly increased the extent of cell fusion compared to that with the non-syncytium-inducing MLV FB29. Surprisingly, we also observed that TR1.3 and W102G Envs failed to elicit syncytium formation in these in vitro assays. Coexpression of gag-pol with env restored syncytium formation, and accordingly, mutations within gag-pol were used to examine the minimal functional requirements for the SI phenotype. The results indicate that both gag-dependent particle budding and cleavage of p2E are required to activate the SI phenotype of TR1.3 and W102G viruses. Collectively, these data suggest that the TR1.3 and W102G viruses induce cell fusion by the fusion-from-without pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634219      PMCID: PMC2045439          DOI: 10.1128/JVI.00816-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Authors:  J E Garrus; U K von Schwedler; O W Pornillos; S G Morham; K H Zavitz; H E Wang; D A Wettstein; K M Stray; M Côté; R L Rich; D G Myszka; W I Sundquist
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

2.  A 100-amino acid truncation in the cytoplasmic tail of glycoprotein 41 in the reference HIV type 1 strain RF.

Authors:  Darren R Jones; Kazuo Suzuki; Sabine C Piller
Journal:  AIDS Res Hum Retroviruses       Date:  2002-05-01       Impact factor: 2.205

3.  In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.

Authors:  H Blaak; A B van't Wout; M Brouwer; B Hooibrink; E Hovenkamp; H Schuitemaker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

4.  Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation.

Authors:  G B Melikyan; R M Markosyan; S A Brener; Y Rozenberg; F S Cohen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.

Authors:  B Yuan; S Campbell; E Bacharach; A Rein; S P Goff
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study.

Authors:  J J Maas; S J Gange; H Schuitemaker; R A Coutinho; R van Leeuwen; J B Margolick
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

7.  Genetic assay for multimerization of retroviral gag polyproteins.

Authors:  J Luban; K B Alin; K L Bossolt; T Humaran; S P Goff
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

8.  Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo.

Authors:  B Etemad-Moghadam; Y Sun; E K Nicholson; M Fernandes; K Liou; R Gomila; J Lee; J Sodroski
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus.

Authors:  Samuel L Murphy; Maeran Chung-Landers; Marek Honczarenko; Glen N Gaulton
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

10.  Identification of R-peptides in envelope proteins of C-type retroviruses.

Authors:  Maria Bobkova; Joern Stitz; Martin Engelstädter; Klaus Cichutek; Christian J Buchholz
Journal:  J Gen Virol       Date:  2002-09       Impact factor: 3.891

View more
  3 in total

1.  Unique N-linked glycosylation of CasBrE Env influences its stability, processing, and viral infectivity but not its neurotoxicity.

Authors:  Krystal M Renszel; Russell S Traister; William P Lynch
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

2.  A mutant retroviral receptor restricts virus superinfection interference and productive infection.

Authors:  Meihong Liu; Maribeth V Eiden
Journal:  Retrovirology       Date:  2012-06-12       Impact factor: 4.602

3.  Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without.

Authors:  Samuel A Theuerkauf; Alexander Michels; Vanessa Riechert; Thorsten J Maier; Egbert Flory; Klaus Cichutek; Christian J Buchholz
Journal:  iScience       Date:  2021-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.